MARLENA OSOWSKI: Open Payments
NPI 1386335776 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$112 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $393 · 2025 $112
Food & beverage: $112
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $39 |
| Gilead Sciences, Inc. | 1 | $22 |
| Lucid Diagnostics Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
Products named: DUPIXENT, ENTYVIO, MOUNJARO.
Industry payments across MA — which companies pay providers there.
